Parkinsons: Drug Could Stall Worsening Symptoms Participants in a phase II trial with Parkinsons who took an older GLP-1 called lixisenatide saw no worsening of motor function symptoms over a year, compared to the placebo group who did see intensified symptoms
The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death." $99 vs $198 Cora vs Eden monthly cost (updated July 2026)
Research indicates that propionate undergoes conversion to glucose through intestinal gluconeogenesis prior to reaching the liver, conferring metabolic advantages in maintaining energy equilibrium (De Vadder et al., 2014)
bodybuilding for all
And insurance coverage has been tricky to navigate for a lot of people
doi: 10.1158/1538-7445.AM2024-4366 121 WangSQXiangJZhangGQFuLYXuYNChenYet al